Abstract: A clinical data processing system comprising a processor; a memory operatively coupled to the processor, the memory storing executable instructions providing a user interface module configured to receive participant data and store it as participant data in the memory; a schema management module configured to receive input via the user interface module, the schema management module comprising rules for determining withholding amounts for payments due to a participant in view of applicable schema data and participant data stored in the memory; and a participation aggregation module configured to receive input via the user interface module, the participation aggregation module comprising rules for determining whether to permit or defer payments due to the participant in view of aggregated payments due to a participant as reflected in participant data stored in the memory.
Type:
Grant
Filed:
June 3, 2019
Date of Patent:
December 5, 2023
Assignee:
GREENPHIRE, LLC
Inventors:
Kyle Russell Cunningham, Zachary Andrew Hales
Abstract: An automated method and computer program product are provided for reporting payments made to patients for their participation in a clinical study in a blinded manner to the sponsor of the clinical study. The clinical study has a plurality of investigative sites which perform activities in accordance with the protocol of the clinical study. Each patient has patient ID information and is assigned a subject ID that de-identifies the patient. Payment requests are received at a software application from the investigative sites associated with patient activity. The software application includes for each patient that is participating in the clinical study, the patient ID information, and the de-identified subject ID. The payment requests are associated with the patient ID information. The payment requests are processed at the software application, and payments that conform to predefined compensation guidelines for the clinical study are approved.
Abstract: An automated method and computer program product are provided for reporting payments made to patients for their participation in a clinical study in a blinded manner to the sponsor of the clinical study. The clinical study has a plurality of investigative sites which perform activities in accordance with the protocol of the clinical study. Each patient has patient ID information and is assigned a subject ID that de-identifies the patient. Payment requests are received at a software application from the investigative sites associated with patient activity. The software application includes for each patient that is participating in the clinical study, the patient ID information, and the de-identified subject ID. The payment requests are associated with the patient ID information. The payment requests are processed at the software application, and payments that conform to predefined compensation guidelines for the clinical study are approved.